BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31677808)

  • 1. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections].
    Baghad B; Benhsaien I; El Fatoiki FZ; Migaud M; Puel A; Chiheb S; Bousfiha AA; Ailal F
    Ann Dermatol Venereol; 2020 Jan; 147(1):41-45. PubMed ID: 31677808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
    Carey B; Lambourne J; Porter S; Hodgson T
    Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
    Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
    Front Immunol; 2020; 11():967. PubMed ID: 32547544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function STAT1 mutations are associated with intracranial aneurysms.
    Dadak M; Jacobs R; Skuljec J; Jirmo AC; Yildiz Ö; Donnerstag F; Baerlecken NT; Schmidt RE; Lanfermann H; Skripuletz T; Schwenkenbecher P; Kleinschnitz C; Tumani H; Stangel M; Pul R
    Clin Immunol; 2017 May; 178():79-85. PubMed ID: 28161409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.
    Haake K; Wüstefeld T; Merkert S; Lüttge D; Göhring G; Auber B; Baumann U; Lachmann N
    Stem Cell Res; 2020 Mar; 43():101713. PubMed ID: 32000109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 gain-of-function and chronic demodicosis.
    Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
    Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: A New Gain-of-Function Mutation of
    Martinot M; Korganow AS; Wald M; Second J; Birckel E; Mahé A; Souply L; Mohseni-Zadeh M; Droy L; Tarabeux J; Okada S; Migaud M; Puel A; Guffroy A
    Front Immunol; 2021; 12():760019. PubMed ID: 34987506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Disseminated
    Chen K; Tan J; Qian S; Wu S; Chen Q
    Front Immunol; 2021; 12():682350. PubMed ID: 34421897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
    Okada S; Asano T; Moriya K; Boisson-Dupuis S; Kobayashi M; Casanova JL; Puel A
    J Clin Immunol; 2020 Nov; 40(8):1065-1081. PubMed ID: 32852681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
    Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
    J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchiectasis and Recurrent Respiratory Infections with a
    Huh HJ; Jhun BW; Choi SR; Kim YJ; Yun SA; Nham E; Kong T; Ki CS; Koh WJ
    Yonsei Med J; 2018 Oct; 59(8):1004-1007. PubMed ID: 30187709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
    Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
    J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
    Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
    Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
    Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review.
    Wang X; Zhao W; Chen F; Zhou P; Yan Z
    Mycopathologia; 2023 Apr; 188(1-2):87-97. PubMed ID: 36335528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
    Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
    Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and recurrent STAT1 mutations in seven Chinese patients with chronic mucocutaneous candidiasis.
    Wang X; Zhang R; Wu W; Wang A; Wan Z; van de Veerdonk FL; Li R
    Int J Dermatol; 2017 Feb; 56(2):e30-e33. PubMed ID: 27808400
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
    Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
    Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.
    Toubiana J; Okada S; Hiller J; Oleastro M; Lagos Gomez M; Aldave Becerra JC; Ouachée-Chardin M; Fouyssac F; Girisha KM; Etzioni A; Van Montfrans J; Camcioglu Y; Kerns LA; Belohradsky B; Blanche S; Bousfiha A; Rodriguez-Gallego C; Meyts I; Kisand K; Reichenbach J; Renner ED; Rosenzweig S; Grimbacher B; van de Veerdonk FL; Traidl-Hoffmann C; Picard C; Marodi L; Morio T; Kobayashi M; Lilic D; Milner JD; Holland S; Casanova JL; Puel A;
    Blood; 2016 Jun; 127(25):3154-64. PubMed ID: 27114460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
    Hori T; Ohnishi H; Teramoto T; Tsubouchi K; Naiki T; Hirose Y; Ohara O; Seishima M; Kaneko H; Fukao T; Kondo N
    J Clin Immunol; 2012 Dec; 32(6):1213-20. PubMed ID: 22847544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.